Mindera Health™ Welcomes New Vice President of Sales
05 déc. 2024 08h00 HE
|
Mindera Health
Vista, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Mindera Health, a pioneer in precision medicine combining machine learning with Next-Generation Sequencing to create Dermal Intelligence™, announces the...
Philips aims to advance cardiac MRI technology through AI-driven research
03 déc. 2024 09h00 HE
|
Royal Philips
December 3, 2024 Collaboration intends to leverage proprietary AI technology from Philips and Mayo Clinic to target breakthroughs in ease-of-use and efficiency to bring high-quality diagnostic MRI...
Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific
03 déc. 2024 08h35 HE
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Exosome Research Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Exosome...
Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024
01 déc. 2024 10h00 HE
|
Royal Philips
December 1, 2024 Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more...
Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24
01 déc. 2024 09h00 HE
|
Royal Philips
December 1, 2024 Philips' intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely position the company to drive precision imaging...
Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24
25 nov. 2024 09h00 HE
|
Royal Philips
November 25, 2024icometrix’ FDA-cleared quantitative brain solution for neurological conditions including Alzheimer’s and multiple sclerosis is seamlessly integrated into Philips next generation...
Silexion Therapeutics Announces 1-for-9 Reverse Share Split
22 nov. 2024 16h30 HE
|
Silexion Therapeutics Corp
GRAND CAYMAN, Cayman Islands, November 22, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for...
Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24
21 nov. 2024 04h15 HE
|
Royal Philips
Nov. 21, 2024 Industry’s first wide bore, high-performance helium-free [1] 1.5T MR features AI assistance at every step in the MRI workflow, with seamless integration of cloud-based AI image reading...
Spatial Genomics and Transcriptomics Research Analysis Report 2024-2030: Emergence of High-Throughput Sequencing Platforms Fuels Market Growth
20 nov. 2024 11h05 HE
|
Research and Markets
Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Spatial Genomics and Transcriptomics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
20 nov. 2024 08h30 HE
|
Silexion Therapeutics Corp
GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers,...